Functional analysis of three genetic polymorphisms in the glucocorticoid receptor gene

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 1, 2003, Pages 110-116

  Koyano, Satoru ^a   Saito, Yoshiro ^a   Nagano, Michiyo ^a   Maekawa, Keiko ^a   Kikuchi, Yutaka ^a   Murayama, Norie ^a   Fujino, Tomofumi ^a   Ozawa, Shogo ^a   Nakajima, Toshiharu ^b   Matsumoto, Kenji ^b   Saito, Hirohisa ^b   Sawada, Jun Ichi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION; HUMANS; NF-KAPPA B; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TIME FACTORS; TRANSFECTION;

EID: 0141742521     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.054155     Document Type: Article

References (32)

1. Berrebi D, Bruscoli S, Cohen N, Foussat A, Migliorati G, Bouchet-Delbos L, Maillot MC, Portier A, Couderc J, Galanaud P, et al. (2003) Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101:729-738.
2. Brown T and Mackey K (1997) Analysis of RNA by Northern and slot blot hybridization, in Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K eds), John Wiley & Sons, Inc., New York.
3. Byers PH (2002) Killing the messenger: new insights into nonsense-mediated mRNA decay. J Clin Invest 109:3-6.
4. De Bosscher K, Vanden Berghe W, and Haegeman G (2000) Mechanisms of antiinflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 109:16-22.
5. DeRijk RH, Schaaf M, and de Kloet ER (2002) Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 81:103-122.
6. Encio IJ and Detera-Wadleigh SD (1991) The genomic structure of the human glucocorticoid receptor. J Biol Chem 266:7182-7188.
7. Giguere V, Hollenberg SM, Rosenfeld MG, and Evans RM (1986) Functional domains of the human glucocorticoid receptor. Cell 46:645-652.
8. Gustafsson JA, Wikstrom AC, and Denis M (1989) The non-activated glucocorticoid receptor: structure and activation. J Steroid Biochem 34:53-62.
9. Jiang T, Liu S, Tan M, Huang F, Sun Y, Dong X, Guan W, Huang L, and Zhou F (2001) The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clin Chim Acta 313:113-117.
10. Kino T, Stauber RH, Resau JH, Pavlakis GN, and Chrousos GP (2002) Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86:5600-5608.
11. Koura M and Isaka H (1980) Establishment of a human colon adenocarcinoma cell line producing carcinoembryonic antigen. Jpn J Cancer Clin 71:313-318.
12. Koyano S, Kurose K, Ozawa S, Saeki M, Nakajima Y, Hasegawa R, Komamura K, Ueno K, Kamakura S, Nakajima T, et al. (2002) Eleven novel single nucleotide polymorphisms in the NRiI2 (PXR) gene, four of which induce non-synonymous amino acid alterations. Drug Metab Pharmacokinet 17:561-565.
13. Loke TK, Sousa AR, Corrigan CJ, and Lee TH (2002) Glucocorticoid-resistant asthma. Curr Allergy Asthma Rep 2:144-150.
14. McKay LI and Cidlowski JA (2000) CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14:1222-1234.
15. Medh RD and Schmidt TJ (1997) Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells. J Steroid Biochem Mol Biol 62:129-142.
16. Mittelstadt PR and Ashwell JD (2001) Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276:29603-29610.
17. Moalli PA, Pillay S, Krett NL, and Rosen ST (1993) Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Res 53:3877-3879.
18. Nagano M, Nakamura T, Niimi S, Fujino T, Nishimura T, Murayama N, Ishida S, Ozawa S, Saito Y, and Sawada J (2002) Substitution of arginine for cysteine 643 of the glucocorticoid receptor reduces its steroid-binding affinity and transcriptional activity. Cancer Lett 181:109-114.
19. Nissen RM and Yamamoto KR (2000) The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14:2314-2329.
20. Panarelli M, Holloway CD, Fraser R, Connell JM, Ingram MC, Anderson NH, and Kenyon CJ (1998) Glucocorticoid receptor polymorphism, skin vasoconstriction and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 83:1846-1852.
21. Pratt WB and Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360.
22. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541.
23. Reinhard C, Shamoon B, Shyamala V, and Williams LT (1997) Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J 16:1080-1092.
24. Ruiz M, Lind U, Gafvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wikstrom AC, and Werner S (2001) Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol 55:363-371.
25. Sakurai Y, Hirohashi S, Shimosato Y, Kodaira S, and Abe O (1988) Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients. Cancer Res 48:4053-4058.
26. Sanchez ER, Housley PR, and Pratt WB (1986) The molybdate-stabilized glucocorticoid binding complex of L-cells contains a 98-100 kdalton steroid binding phosphoprotein and a 90 kdalton nonsteroid-binding phosphoprotein that is part of the murine heat-shock complex. J Steroid Biochem 24:9-18.
27. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ, and Lefebvre YA (1999) Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19:1025-1037.
28. Simpson SB and Stoltzfus CM (1994) Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels. Mol Cell Biol 14:1835-1844.
29. Vottero A and Chrousos GP (1999) Glucocorticoid receptor beta: view I. Trends Endocrinol Metab 10:333-338.
30. Vottero A, Kino T, Combe H, Lecomte P, and Chrousos GP (2002) A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87:2658-2667.
31. Webster JC and Cidlowski JA (1999) Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol Metab 10:396-402.
32. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, and Cidlowski JA (1997) Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272:9287-9293.